Bill & Melinda Gates Foundation
P.O. Box 23350
166 articles with Bill & Melinda Gates Foundation
It’s been a busy day so far for biopharma news and updates. Read on for more.
Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world
Gates Foundation pledges additional $250 million to accelerate development and equitable distribution of COVID-19 tests, treatments, and vaccines to end the pandemic
Merck Advances Phase 3 Trial to Evaluate Investigational Islatravir as Once-Monthly Oral PrEP for Women at High Risk for Acquiring HIV-1
Collaboration with the Bill & Melinda Gates Foundation Seeks to Bring Forward a New HIV Prevention Option to Help Address the HIV Epidemic with Focus on Women in Sub-Saharan Africa
Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease Treatments
Intellia Therapeutics, Inc. (NASDAQ:NTLA), announced that it has received a grant from the Bill & Melinda Gates Foundation to research in vivo sickle cell disease (SCD) treatments using its CRISPR/Cas9 genome editing technology. This pilot development program is part of the Gates Foundation’s broade
Evotec SE announced that its Seattle-based subsidiary, Just - Evotec Biologics, Inc., received a grant from the Bill & Melinda Gates Foundation as part of the COVID-19 Therapeutics Accelerator to enable the development and production of monoclonal antibody candidates for the prevention of severe COVID-19 in vulnerable populations in low and middle income countries.
Lilly Announces Arrangement for Supply of Potential COVID-19 Antibody Therapy for Low- and Middle-Income Countries
Eli Lilly and Company and the Bill & Melinda Gates Foundation, as part of the COVID-19 Therapeutics Accelerator, have entered into an agreement to facilitate access to future Lilly therapeutic antibodies under development for the prevention and treatment of COVID-19, the disease caused by the SARS-CoV-2 novel coronavirus, to benefit low- and middle-income countries.
Statement from Bill & Melinda Gates Foundation CEO Mark Suzman on Momentum in Global COVID-19 Response
The death toll from COVID-19 passed one million this week. It is a sobering moment. But there is cause for optimism as recent days have seen a significant surge in momentum around global cooperation, which is our greatest strength when it comes to consigning this pandemic to the history books.
Acceligen, a Recombinetics Inc. company, today announced that it received a grant from the Bill & Melinda Gates Foundation to develop bovine genetics optimized with traits desirable to smallholder dairy farmers. The breeding program will contribute to more sustainable production by using traits that will increase farmer income
Foundation also announces three Global Goals award winners and launches two innovative partnerships to address COVID-19 impacts in Kenya
Gates Foundation's Annual Goalkeepers Report Shows COVID-19 Has Stalled 20 Years of Progress, Calls for Global Response to End the Pandemic
Report shows how economic damage has reinforced inequities and derailed achievement of the UN Sustainable Development Goals; spotlights countries innovating to meet challenges
Relation Therapeutics, a drug development company driven by data science and machine learning, announces Project RE, which will apply Relation Therapeutics’ and its partners’ technology to the identification of repurposed drug combinations as potential therapeutic candidates for COVID-19.
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.
Dynavax Announces Grant to Scale up CpG 1018 Adjuvant Capacity to Support the Global COVID-19 Response
Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a grant from the Bill & Melinda Gates Foundation of $3.4 million to scale up production batch size to allow for increased capacity of Dynavax’s CpG 1018 advanced adjuvant to support the global COVID-19 response. These efforts will support capacity of up to 750 million adjuvant d
HJF Medical Research International (HJFMRI), a wholly owned subsidiary of The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) , was awarded $1.3M by the Bill & Melinda Gates Foundation to support antenatal, intrapartum and postnatal care in the Kenya Child Health and Mortality Surveillanc
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.
Kleo Pharmaceuticals Announces $5 Million Grant to Advance Development of COVID-19 Hyperimmune Globulin Mimic (HGM) as a Therapeutic for Infected Patients
The Grant from the Bill & Melinda Gates Foundation Accelerates Company’s Efforts to Enter Clinical Trials by Early 2021
Daré Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible Contraceptive
Contraceptive Program Supported by up to $20.5 Million in Grant Funding from the Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation pledges $1.6 billion to Gavi, the Vaccine Alliance, to protect the next generation with lifesaving vaccines
Global leaders unite to safeguard 300 million more children from disease and mitigate consequences of COVID-19
New online portal provides 'real-time' support and latest evidence for hygiene interventions actors, supported by funding from DFID and Bill & Melinda Gates Foundation
New Research Highlights Disparity of Economic, Educational, and Social Impact of COVID-19 Based on Race, Gender, and Income
Data science firm Civis Analytics released new findings from its COVID-19 Impact Research, funded by the Bill & Melinda Gates Foundation.